RDY

Dr. Reddy's Laboratories Limited

Healthcare›Drug Manufacturers - Specialty & Generic|New York Stock Exchange|IN

Price

$13.32

Market Cap

$11.09B

Beta

0.31

P/E

0.2

Div Yield

—

Sector Median P/E

22.6

Key Metrics

Revenue Growth (YoY)+11.09%

EPS Growth (YoY)+5.50%

Revenue CAGR 3Y+41.77%

P/E Ratio0.2

PEG Ratio—

FCF Yield+218.79%

Debt / Equity0.18

Interest Coverage20.0x

No credit card required

Already have an account? Sign in to view the full analysis for RDY.